» Articles » PMID: 37434830

LncRNA SNHG20 Silencing Inhibits Hepatocellular Carcinoma Progression by Sponging MiR-5095 from MBD1

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2023 Jul 12
PMID 37434830
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Long non-coding RNAs (lncRNAs) may have a significant regulatory effect on the progression of hepatocellular carcinoma (HCC), according to recent data. This study aims to investigate how SNHG20, a small nucleolar RNA host gene, contributes to the development of HCC.

Methods: LncRNA SNHG20, miR-5095, and MBD1 gene levels were determined using reverse transcription qPCR (RT-qPCR). Huh-7 and HepG2 cell bioactivities were evaluated using the CCK-8 kit, EdU, flow cytometry, and wound-healing migration tests. To assess the metastasis of Huh-7 and HepG2 cells, a transwell assay was used. The amounts of invasion- and proliferation-associated proteins were determined using western blot. Using the miRDB (www.mirdb.org) software, the possible target genes of lncRNA and miRNA were predicted, and this prediction was then verified by a twofold luciferase reporter test. To determine the pathologic alteration and Ki67 level in tumor tissues, H&E staining and IHC were employed. TUNEL was conducted to assess the presence of apoptotic bodies in the tumor tissues.

Results: lncRNA SNHG20 exhibited a high expression in HCC cells (P<0.01). LncRNA SNHG20 knockdown inhibited HCC cell metastasis (P<0.01) and accelerated apoptosis (P<0.01). LncRNA SNHG20 acted as a sponge of miR-5095 in HCC. In addition, miR-5095 overexpression inhibited HCC cell metastasis (P<0.01) and accelerated apoptosis (P<0.01); and miR-5095 negatively targeted MBD1. Furthermore, LncRNA SNHG20 regulated HCC progression through the miR-5095/MBD1 axis, and LncRNA SNHG20 knockdown inhibited HCC growth.

Conclusion: LncRNA SNHG20 accelerates HCC progression by the miR-5095/MBD1 axis, indicating lncRNA SNHG20 can be used as a biomarker for patients with HCC.

Citing Articles

Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.

Tian Y, Zhang M, Liu L, Wang Z, Liu B, Huang Y Front Immunol. 2024; 15:1400744.

PMID: 38799446 PMC: 11116607. DOI: 10.3389/fimmu.2024.1400744.

References
1.
Zhao H, Zheng G, Li G, Xin L, Wang Y, Chen Y . Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer. J Cell Physiol. 2019; 234(12):23349-23359. DOI: 10.1002/jcp.28902. View

2.
Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C . Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019; 18(1):78. PMC: 6446409. DOI: 10.1186/s12943-019-0990-6. View

3.
Ding Y, Wang H, Shen H, Li Z, Geng J, Han H . The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003; 200(3):282-9. PMC: 7168017. DOI: 10.1002/path.1440. View

4.
Kondo Y, Shinjo K, Katsushima K . Long non-coding RNAs as an epigenetic regulator in human cancers. Cancer Sci. 2017; 108(10):1927-1933. PMC: 5623749. DOI: 10.1111/cas.13342. View

5.
Elton T, Selemon H, Elton S, Parinandi N . Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2012; 532(1):1-12. DOI: 10.1016/j.gene.2012.12.009. View